BIOHYALUX润百颜品牌怎么样 申请店铺

我要投票 BIOHYALUX润百颜在玻尿酸行业中的票数:182 更新时间:2025-04-02
BIOHYALUX润百颜是哪个国家的品牌?「BIOHYALUX润百颜」是 北京华熙海御科技有限公司 旗下著名品牌。该品牌发源于北京,由创始人赵燕在2011期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力BIOHYALUX润百颜品牌出海!通过在本页面挂载BIOHYALUX润百颜品牌的产品链接和联系邮箱,可以提高BIOHYALUX润百颜产品曝光!跨境电商爆单神器,目前只要100元/年哦~

BIOHYALUX润百颜怎么样

华熙生物科技有限公司是致力于生物医药领域发展的国际集团公司,旗下包括近10家医药生产公司、销售公司及投资公司。2008年10月3日,在香港联交所上市(股票代码:00963.HK)。北京华熙海御科技有限公司是华熙生物科技有限公司旗下,专门从事透明质酸系列产品的品牌推广、市场营销及客户服务的企业,业务范围涉及医药、整形美容、化妆品和保健食品等领域,营销网络遍及全球。

华熙福瑞达生物医药有限公司,作为华熙生物科技有限公司的主要经营附属公司,20余年专注于透明质酸研发生产的高新技术企业,为世界知名制药、化妆品和保健食品企业持续提供安全、稳定、可靠的透明质酸原料,是目前全球最专业、规模及产量最大的透明质酸原料生产企业,所占全球市场份额超过30%,中国市场份额达到70%。持续研发创新和对质量管理体系的高度重视是公司成为业内翘楚的重要因素。

在20余年的研发历程中,我们实现了两大填补国际和国内空白的研发突破:

1)1990年,发酵法生产透明质酸首先在国内研制成功——是透明质酸产业化进程中的革命性技术创新,不仅实现了透明质酸的规模化生产,更提高了产品质量。

2)2011年,全球首家实现酶切法生产寡聚透明质酸(纳诺HA?)的产业化,同年,纳诺HA?正式上市,实现了为化妆品企业提供结构完整、可透皮吸收的透明质酸原料。

我们坚信“质量是维护客户忠诚的基本保证”,始终致力于建立完善的质量管理体系。严格按照GMP、ISO9001质量体系进行管理,保证产品质量的可靠性和稳定性。公司是国内具有发酵法生产透明质酸药用辅料及原料药批准文号并通过GMP认证的生产企业。

我们按照ICHQ7要求生产的注射级玻璃酸钠,质量高于欧洲和日本药典标准,获得了欧盟CEP证书和美国DMF登记号,并且顺利通过美国FDA的现场审核。公司是中国透明质酸美容整形填充剂标准起草单位;2015版中国药典透明质酸钠标准起草单位;中国化妆品用透明质酸钠行业标准起草单位,化妆品级透明质酸钠产品于2011年通过国际ECOCERT有机化妆品原料认证。

公司在国内率先启动了新资源食品透明质酸的注册申报,成为国内首家获得新资源食品透明质酸生产资质的企业。食用级透明质酸已通过国际Kosher犹太洁食和Halal清真食品认证。

我们致力于将美丽的事业从透明质酸原料延续到医药、整形美容、化妆品和保健食品等领域,也将一如既往地沿着专业的道路,为国产品牌、为美丽世界,持续努力!

科技成就美丽!

Huaxi Biotechnology Co., Ltd. is an international group company dedicated to the development of biomedical field, including nearly 10 pharmaceutical production companies, sales companies and investment companies. On October 3, 2008, it was listed on the Hong Kong Stock Exchange (Stock Code: 00963. HK). Beijing huaxihaiyu Technology Co., Ltd. is a company under Huaxi Biotechnology Co., Ltd. which specializes in the brand promotion, marketing and customer service of hyaluronic acid series products. Its business scope covers the fields of medicine, plastic and beauty, cosmetics and health food. Its marketing network covers the world. Huaxi furida biomedical Co., Ltd., as the main subsidiary of Huaxi Biotechnology Co., Ltd., is a high-tech enterprise focusing on the research and development and production of hyaluronic acid for more than 20 years. It continuously provides safe, stable and reliable hyaluronic acid raw materials for world-famous pharmaceutical, cosmetics and health food enterprises. It is the most professional, largest scale and largest production of hyaluronic acid in the world Acid raw material manufacturers account for more than 30% of the global market and 70% of the Chinese market. Continuous R & D innovation and high attention to quality management system are important factors for the company to become the leader in the industry. In more than 20 years of R & D process, we have achieved two major R & D breakthroughs to fill the international and domestic gaps: 1) in 1990, the production of hyaluronic acid by fermentation was first developed successfully in China, which is a revolutionary technological innovation in the process of hyaluronic acid industrialization, not only realizing the large-scale production of hyaluronic acid, but also improving the product quality. 2) In 2011, the world's first industrialization of enzymatic production of oligohyaluronic acid (NANOHA?) was realized. In the same year, NANOHA? Was officially listed, which realized to provide cosmetics enterprises with transparent acid raw materials with complete structure and transdermal absorption. We firmly believe that "quality is the basic guarantee to maintain customer loyalty", and are always committed to establishing a sound quality management system. Strictly in accordance with GMP, ISO9001 quality system management, to ensure the reliability and stability of product quality. The company is a domestic manufacturer with the approval number of hyaluronic acid pharmaceutical excipients and APIs produced by fermentation and GMP certification. Our injection grade sodium hyaluronate produced in accordance with the requirements of ichq7 is higher than the European and Japanese Pharmacopoeia standards, has obtained the European CEP certificate and the US DMF registration number, and has successfully passed the on-site audit of the US FDA. The company is the drafter of the standards for hyaluronic acid cosmetic fillers in China; the drafter of the standards for sodium hyaluronate in Chinese Pharmacopoeia 2015; the drafter of the industry standards for sodium hyaluronate used in cosmetics in China, and the cosmetics grade sodium hyaluronate products passed the international Ecocert organic cosmetics raw material certification in 2011. The company took the lead in launching the registration and application of new resource food hyaluronic acid in China, becoming the first enterprise in China to obtain the qualification of new resource food hyaluronic acid production. Food grade hyaluronic acid has passed the international kosher kosher kosher and Halal halal halal halal food certification. We are committed to continue the beautiful business from hyaluronic acid raw materials to medicine, plastic and beauty, cosmetics and health food and other fields, and will continue to work hard for domestic brands and the beautiful world as always along the professional path! Technology makes beauty!

本文链接: https://brand.waitui.com/028496a80.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

加力扩围发力显效,“两新”政策激发消费活力

4月1日,国家发展改革委消息显示,今年前两个月,“两新”政策进一步发力显效,带动设备工器具购置投资同比增长18%,社会消费品零售总额同比增长4%,继续发挥扩消费、稳投资、促转型、惠民生的重要作用。国家发展改革委指出,“两新”政策有效激发了消费活力。今年超长期特别国债支持消费品以旧换新资金规模增加至3000亿元,相较去年的资金规模翻了一番。首批810亿元资金于1月6日第一时间下达,延续2024年工作基础,扩围支持手机、平板、智能手表手环等数码产品购新。(证券时报)

2小时前

2024年中国为欧盟汽车进口最大来源国

4月1日,欧盟发布2024年欧盟汽车行业贸易数据,中国以127亿欧元进口额成为欧盟汽车进口最大来源国,欧方称,2019-2024五年间,欧盟自中国进口汽车增幅高达1591.3%;尽管如此,2024年欧盟对华汽车贸易保持顺差,对华出口高达145亿欧元。2024年,欧盟共出口汽车540万辆,进口汽车400万辆。与2019年相比,出口数量下降了13.2%,进口数量则减少了3.0%。(界面)

2小时前

业绩承诺仅完成6.7%,三鑫医疗高溢价投资面临追偿难

三年累计不低于4200万元的业绩承诺,实际完成280.42万元,完成率仅为6.7%,业绩承诺方暂时无法拿出充足的资金进行股份回购补偿。近日,三鑫医疗一则关于参股公司业绩承诺实现情况专项说明的公告引发众多投资者关注。有受访投行人士分析,高业绩承诺对应的一定是高估值,高估值就意味着高风险,这也提醒上市公司在投资时要紧紧围绕自身战略进行布局,真正做好风险控制。(上证报)

2小时前

全球风险资产震荡,市场静待关税靴子落地

美国即将于4月2日启动对等关税,引发市场连锁反应。美股三大指数上周集体下挫,亚太市场同步承压,避险资金则推动黄金现货价格触及3149.03美元/盎司的历史高位。随着政策实施时点临近,市场对美国经济政策框架的能见度逐步提升。部分机构表示,政策的可预测性上升,积极信号正在酝酿;也有机构对风险资产的表现感到担忧。尽管短期波动性骤增,但市场普遍认为,4月2日将为接下来几个月的金融市场走向定下基调。(中证网)

2小时前

中信建投:电解铝强调清洁能源代替,绿证市场有望加速成长

36氪获悉,中信建投证券研报显示,近期,工业和信息化部等十部门发布关于印发《铝产业高质量发展实施方案(2025—2027年)》。具体来看,《方案》鼓励企业参与光伏、风电等可再生能源和氢能、储能系统开发建设。推进氢氧化铝焙烧、铝用阳极焙烧环节实施清洁能源替代。在我国能耗双控转型的背景下,高耗能企业的清洁用能替代需求有望持续增长,有助于绿电、绿证市场的加速发展,有利于风光项目环境价值的兑现。

2小时前

本页详细列出关于逆时光 INVERSE TIME的品牌信息,含品牌所属公司介绍,逆时光 INVERSE TIME所处行业的品牌地位及优势。
咨询